CN204758608U - Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method - Google Patents
Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method Download PDFInfo
- Publication number
- CN204758608U CN204758608U CN201520395627.1U CN201520395627U CN204758608U CN 204758608 U CN204758608 U CN 204758608U CN 201520395627 U CN201520395627 U CN 201520395627U CN 204758608 U CN204758608 U CN 204758608U
- Authority
- CN
- China
- Prior art keywords
- test strips
- pad
- container
- clamping device
- colloidal gold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 52
- 239000008280 blood Substances 0.000 title claims abstract description 52
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 title claims abstract description 17
- 102000055006 Calcitonin Human genes 0.000 title abstract 3
- 108060001064 Calcitonin Proteins 0.000 title abstract 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 3
- 229960004015 calcitonin Drugs 0.000 title abstract 3
- 238000012360 testing method Methods 0.000 claims abstract description 77
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 31
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 238000005507 spraying Methods 0.000 claims abstract description 5
- 108010048233 Procalcitonin Proteins 0.000 claims description 30
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 claims description 30
- 206010059484 Haemodilution Diseases 0.000 claims description 27
- 239000003085 diluting agent Substances 0.000 claims description 9
- 241001463139 Vitta Species 0.000 claims description 3
- 239000007788 liquid Substances 0.000 abstract 2
- 241000283707 Capra Species 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 3
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000012898 sample dilution Substances 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
The utility model provides a detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method, which comprises an outer shell, the test paper strip, test paper strip clamping device, the colorimetric card, disposable quantitative blood taking needle, blood dilutes the container, set up the transparent window on the shell, set up test paper strip clamping device and colorimetric card among the shell cavity under the transparent window, the test paper strip is fixed to test paper strip clamping device centre gripping, be provided with disposable quantitative blood taking needle in the shell recess, disposable quantitative blood taking needle passes through pipe connection blood and dilutes the container, blood dilutes the container and passes through pipe connection weak solution container, blood dilutes the container and connects a liquid pipe one end, it is located test paper strip top to go out the liquid pipe other end, the test paper strip includes that appearance pad, spraying colloidal gold labelled antibody and colloid carbon labelled antibody's combination pad, peridium has former monoclonal antibody of calcitonin and goat -anti rabbit polyclonal antibody's nitrocellulose membranes, the board that absorbs water, backup pad and ka sai, and the patient can own ration gather fingertip blood, contrast measuring.
Description
Technical field
The utility model relates to a kind of pick-up unit, and particularly the pick-up unit of Procalcitonin content in colloidal gold method semiquantitative determination blood sample, belongs to medical equipment field.
Background technology
Procalcitonin (PCT) is to Systemic bacterial Infect And Diagnose and discriminating, the judgement of result for the treatment of and prognosis is than C reactive protein (CRP) and the various inflammatory reaction factor (bacterial endotoxin, TNF-α, IL-2) more responsive, have more value for clinical application.On market, existing PCT external diagnosis reagent is very many, comprise multiple quantitative detecting reagent and qualitative detection reagent, quantitative detecting reagent is in the majority with chemoluminescence method, euzymelinked immunosorbent assay (ELISA), these method complicated operations, and mostly be detection serum sample, therefore need the reviewer of specialty just can operate, be difficult to realize patient and test oneself.Qualitative detection reagent mostly is colloidal gold method, this method is easy and simple to handle, result can be judged by naked eyes, but because patient cannot self-precise acquisition finger tip blood or venous blood, and PCT content number directly affect the judgement of doctor and patient to conditions of patients, therefore this rough method is qualitatively only applicable to examination, and is not suitable for patient home and tests oneself or hospital examines soon, the PD situation of patient cannot being given, providing reference accurately the need of taking microbiotic.
Utility model content
The technical problems to be solved in the utility model is to overcome the deficiencies in the prior art, provides the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample, and patient oneself can be facilitated to detect.
For solving the problems of the technologies described above, the basic conception of the utility model employing technical scheme is:
A pick-up unit for Procalcitonin content in colloidal gold method semiquantitative determination blood sample, comprises shell, test strips, test strips clamping device, colorimetric card, disposable quantitative blood taking needle, hemodilution container.Shell is provided with transparency window, transparency window can folding, test strips clamping device and colorimetric card is respectively arranged with in shell inner cavity under transparency window, test strips gripping apparatus grips fixes test strips, test strips and colorimetric card are arranged side by side, test strips clamping device is connected to enclosure, case surface is provided with groove, disposable quantitative blood taking needle is provided with in groove, disposable quantitative blood taking needle is by tubes connection hemodilution container, hemodilution container is by tubes connection diluent container, hemodilution container connects eluate conduit one end, the eluate conduit other end is positioned at above test strips, test strips comprises loading pad, the pad of spraying colloidal gold labeled monoclonal antibody and colloidal-carbon labelled antibody, be coated with the nitrocellulose filter of Procalcitonin monoclonal antibody and goat-anti rabbit polyclonal antibody, water sucting plate, back up pad and jam, loading pad, pad, nitrocellulose filter, water sucting plate is all positioned in back up pad, loading pad, pad is positioned at nitrocellulose filter one end, part loading pad is overlapped on part pad, part pad is overlapped on nitrocellulose filter, water sucting plate is positioned at the nitrocellulose filter other end and part is overlapped on nitrocellulose filter, nitrocellulose filter is provided with detection line and nature controlling line, arrange and outward extending jam in back up pad both sides, jam and the clamping of test strips clamping device.
Further, test strips clamping device comprises base plate and symmetrically arranged two trough rims on base plate, place test strips in the semi-open groove that the base plate of two trough rims and test strips clamping device is formed, the jam that two trough rims are provided with gap and test strips is connected.
Further, transparency window one end is connected by axle with shell.
Further, the conduit between hemodilution container and diluent container is provided with valve, eluate conduit is provided with valve, hemodilution container connects syringe.
Further, each vitta of colorimetric card is all located at same plane.
The pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination of the utility model blood sample, be configured with disposable quantitative blood taking needle, patient can oneself quantitative collection finger tip blood, quantitative blood taking needle is furnished with quantitative whole blood dilution, directly oneself can complete collection and the dilution of sample in the family, other equipment is not needed to assist, after Sample Dilution is complete, drip appropriate sample in test strips, wait for three minutes just observable testing result, according to the quality-control product testing result of variable concentrations, correspondence is provided with the colorimetric card of Product checking result, it is 0.2ng/ml that this colorimetric card accurately gives PCT concentration when using this detection paper respectively, 0.5ng/ml, 2ng/ml, the colour band color of nature controlling line and detection line during 10ng/ml, thus provide PCT and be less than 0.2ng/ml, 0.2ng/ml ~ 0.5ng/ml, 0.5ng/ml ~ 2ng/ml, 2ng/ml ~ 10ng/ml, be greater than the situation of 10ng/ml five concentration ranges, therefore patient can detect by oneself the contents level learning Procalcitonin in health blood sample, thus to the medication of patient to select to provide guidance.And test strips and colorimetric card are all arranged in the enclosure, and observed by transparency window, prevent pollution.The transparency window that shell is arranged can folding, thus can take out the test strips clamping device of support test strips and then change test strips, and the jam in test strips can prevent test strips from dropping.The utility model can detect whole blood, serum or plasma sample, and patient oneself can be realized can detect in the family, by detection line and the supporting colorimetric card of product are contrasted and can carry out sxemiquantitative judgement to the PCT content in sample, the concentration ranges that sxemiquantitative judges, between 0.2ng/ml ~ 10ng/ml, can meet the needs that family tests oneself.
Accompanying drawing explanation
Fig. 1 is the structural representation of the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination of the utility model blood sample;
Fig. 2 is the structural representation of test strips.
Fig. 3 is the reference significance table of PCT content in blood.
1, shell 2, transparency window 3, test strips 4, colorimetric card 5, quantitatively blood taking needle 31, loading pad 32, pad 33, nitrocellulose filter 34, water sucting plate 35, back up pad 36, jam.
Embodiment
As shown in Figure 1, the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample, comprises shell, test strips, test strips clamping device, colorimetric card, disposable quantitative blood taking needle, hemodilution container.
Shell is provided with transparency window, transparency window can folding, transparency window one end is connected by axle with shell, test strips clamping device and colorimetric card is respectively arranged with in shell inner cavity under transparency window, test strips gripping apparatus grips fixes test strips, test strips and colorimetric card are arranged side by side, and test strips clamping device is connected to enclosure.Each vitta of colorimetric card is all located at same plane.
Case surface is provided with groove, disposable quantitative blood taking needle is provided with in groove, disposable quantitative blood taking needle is by tubes connection hemodilution container, hemodilution container is by tubes connection diluent container, hemodilution container connects eluate conduit one end, and the eluate conduit other end is positioned at above test strips.Conduit between hemodilution container and diluent container is provided with valve, eluate conduit is provided with valve, hemodilution container connects syringe.
Test strips comprises loading pad, spraying colloidal gold labeled monoclonal antibody and the pad of colloidal-carbon labelled antibody, the nitrocellulose filter being coated with Procalcitonin monoclonal antibody and goat-anti rabbit polyclonal antibody, water sucting plate, back up pad and jam,
Loading pad, pad, nitrocellulose filter, water sucting plate are all positioned in back up pad, loading pad, pad are positioned at nitrocellulose filter one end, part loading pad is overlapped on part pad, part pad is overlapped on nitrocellulose filter, water sucting plate is positioned at the nitrocellulose filter other end and part is overlapped on nitrocellulose filter, nitrocellulose filter is provided with detection line and nature controlling line, arranges and outward extending jam, jam and the clamping of test strips clamping device in back up pad both sides.
Test strips clamping device comprises base plate and symmetrically arranged two trough rims on base plate, and place test strips in the semi-open groove that the base plate of two trough rims and test strips clamping device is formed, the jam that two trough rims are provided with gap and test strips is connected.
Can prevent colorimetric card from losing in the enclosure due to colorimetric card or pollute.
As shown in Figure 2, test strips comprises loading pad, the nitrocellulose filter of spraying colloidal gold labeled monoclonal antibody and the pad of colloidal-carbon labelled antibody, Procalcitonin monoclonal antibody and goat-anti rabbit polyclonal antibody, water sucting plate, back up pad and jam.
Loading pad, pad, nitrocellulose filter, water sucting plate are all positioned in back up pad, loading pad, pad are positioned at nitrocellulose filter one end, part loading pad is overlapped on part pad, part pad is overlapped on nitrocellulose filter, water sucting plate is positioned at the nitrocellulose filter other end and part is overlapped on nitrocellulose filter, nitrocellulose filter is provided with detection line and nature controlling line, arranges in back up pad bottom and jam, jam and the clamping of test strips clamping device to downward-extension.
Case surface is provided with groove, disposable quantitative blood taking needle is provided with in groove, disposable quantitative blood taking needle is by tubes connection hemodilution container, hemodilution container is by tubes connection diluent container, hemodilution container connects eluate conduit one end, and the eluate conduit other end is positioned at above test strips.Conduit between hemodilution container and diluent container is provided with valve, eluate conduit is provided with valve, hemodilution container connects syringe.During blood sampling, extract quantitative blood by being delivered to hemodilution container, quantitative dilution is extracted to hemodilution container again by syringe, after hemodilution is completed, close the supravasal valve between hemodilution container and diluent container, open the valve on eluate conduit, the blood utilizing syringe to push dilute in right amount to the loading pad of test strips, and carries out contrast detection according to the detection line that nitrocellulose filter is arranged and nature controlling line and colorimetric card.
And carry out self-inspection reference according to the data in Fig. 3.
The pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination of the utility model blood sample, be configured with disposable quantitative blood taking needle, patient can oneself quantitative collection finger tip blood, quantitative blood taking needle is furnished with quantitative whole blood dilution, directly oneself can complete collection and the dilution of sample in the family, other equipment is not needed to assist, after Sample Dilution is complete, drip appropriate sample in test strips, wait for three minutes just observable testing result, according to the quality-control product testing result of variable concentrations, correspondence is provided with the colorimetric card of Product checking result, it is 0.2ng/ml that this colorimetric card accurately gives PCT concentration when using this detection paper respectively, 0.5ng/ml, 2ng/ml, the colour band color of nature controlling line and detection line during 10ng/ml, thus provide PCT and be less than 0.2ng/ml, 0.2ng/ml ~ 0.5ng/ml, 0.5ng/ml ~ 2ng/ml, 2ng/ml ~ 10ng/ml, be greater than the situation of 10ng/ml five concentration ranges, therefore patient can detect by oneself the contents level learning Procalcitonin in health blood sample, thus to the medication of patient to select to provide guidance.And test strips and colorimetric card are all arranged in the enclosure, and observed by transparency window, prevent pollution.The transparency window that shell is arranged can folding, thus can take out the test strips clamping device of support test strips and then change test strips, and the jam in test strips can prevent test strips from dropping.The utility model can detect whole blood, serum or plasma sample, and patient oneself can be realized can detect in the family, by detection line and the supporting colorimetric card of product are contrasted and can carry out sxemiquantitative judgement to the PCT content in sample, the concentration ranges that sxemiquantitative judges, between 0.2ng/ml ~ 10ng/ml, can meet the needs that family tests oneself.
Embodiment in above-described embodiment can combine further or replace; and embodiment is only be described preferred embodiment of the present utility model; not design of the present utility model and scope are limited; under the prerequisite not departing from the utility model design philosophy; the various changes and modifications that in this area, professional and technical personnel makes the technical solution of the utility model, all belong to protection domain of the present utility model.
Claims (5)
1. the pick-up unit of Procalcitonin content in colloidal gold method semiquantitative determination blood sample, is characterized in that: comprise shell, test strips, test strips clamping device, colorimetric card, disposable quantitative blood taking needle, hemodilution container,
Shell is provided with transparency window, and transparency window can folding, is respectively arranged with test strips clamping device and colorimetric card in the shell inner cavity under transparency window, test strips gripping apparatus grips fixes test strips, test strips and colorimetric card are arranged side by side, and test strips clamping device is connected to enclosure
Case surface is provided with groove, disposable quantitative blood taking needle is provided with in groove, disposable quantitative blood taking needle is by tubes connection hemodilution container, hemodilution container is by tubes connection diluent container, hemodilution container connects eluate conduit one end, and the eluate conduit other end is positioned at above test strips;
Test strips comprises loading pad, spraying colloidal gold labeled monoclonal antibody and the pad of colloidal-carbon labelled antibody, the nitrocellulose filter being coated with Procalcitonin monoclonal antibody and goat-anti rabbit polyclonal antibody, water sucting plate, back up pad and jam,
Loading pad, pad, nitrocellulose filter, water sucting plate are all positioned in back up pad, loading pad, pad are positioned at nitrocellulose filter one end, part loading pad is overlapped on part pad, part pad is overlapped on nitrocellulose filter, water sucting plate is positioned at the nitrocellulose filter other end and part is overlapped on nitrocellulose filter, nitrocellulose filter is provided with detection line and nature controlling line, arranges and outward extending jam, jam and the clamping of test strips clamping device in back up pad both sides.
2. the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample according to claim 1, it is characterized in that: test strips clamping device comprises base plate and symmetrically arranged two trough rims on base plate, place test strips in the semi-open groove that the base plate of two trough rims and test strips clamping device is formed, the jam that two trough rims are provided with gap and test strips is connected.
3. the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample according to claim 1, is characterized in that: transparency window one end is connected by axle with shell.
4. the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample according to claim 1, it is characterized in that: the conduit between hemodilution container and diluent container is provided with valve, eluate conduit is provided with valve, and hemodilution container connects syringe.
5. the pick-up unit of Procalcitonin content in a kind of colloidal gold method semiquantitative determination blood sample according to claim 1, is characterized in that: each vitta of colorimetric card is all located at same plane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520395627.1U CN204758608U (en) | 2015-06-10 | 2015-06-10 | Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520395627.1U CN204758608U (en) | 2015-06-10 | 2015-06-10 | Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204758608U true CN204758608U (en) | 2015-11-11 |
Family
ID=54473303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520395627.1U Expired - Fee Related CN204758608U (en) | 2015-06-10 | 2015-06-10 | Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204758608U (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105954507A (en) * | 2016-04-26 | 2016-09-21 | 北京言必信科技有限公司 | ELISA kit |
| CN106053796A (en) * | 2016-07-15 | 2016-10-26 | 陶少强 | Detecting system and detecting method for PCT chromatography |
| CN106370851A (en) * | 2016-12-03 | 2017-02-01 | 百奥森（江苏）食品安全科技有限公司 | Quick ketamine test device for porcine pseudorabies antibody |
| CN106525837A (en) * | 2016-12-07 | 2017-03-22 | 无锡艾科瑞思产品设计与研究有限公司 | Natamycin determination method and natamycin determination card |
| CN106680478A (en) * | 2017-02-24 | 2017-05-17 | 成都微瑞生物科技有限公司 | Gold labeled detection system and method based on cloud platform |
| CN107860908A (en) * | 2017-11-07 | 2018-03-30 | 兰赫(上海)生物科技有限公司 | Biochemical detection kit for detection and analysis |
| CN109100505A (en) * | 2018-08-22 | 2018-12-28 | 宁波奥丞生物科技有限公司 | A kind of immunofluorescent reagent box of quantitative detection blood vessel endothelium marker CD105 |
| CN111380724A (en) * | 2020-04-24 | 2020-07-07 | 万华普曼生物工程有限公司 | Body fluid sample collecting and inspecting device |
-
2015
- 2015-06-10 CN CN201520395627.1U patent/CN204758608U/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105954507A (en) * | 2016-04-26 | 2016-09-21 | 北京言必信科技有限公司 | ELISA kit |
| CN106053796A (en) * | 2016-07-15 | 2016-10-26 | 陶少强 | Detecting system and detecting method for PCT chromatography |
| CN106053796B (en) * | 2016-07-15 | 2017-09-29 | 陶少强 | A kind of detecting system and detection method chromatographed for PCT |
| CN106370851A (en) * | 2016-12-03 | 2017-02-01 | 百奥森（江苏）食品安全科技有限公司 | Quick ketamine test device for porcine pseudorabies antibody |
| CN106525837A (en) * | 2016-12-07 | 2017-03-22 | 无锡艾科瑞思产品设计与研究有限公司 | Natamycin determination method and natamycin determination card |
| CN106680478A (en) * | 2017-02-24 | 2017-05-17 | 成都微瑞生物科技有限公司 | Gold labeled detection system and method based on cloud platform |
| CN107860908A (en) * | 2017-11-07 | 2018-03-30 | 兰赫(上海)生物科技有限公司 | Biochemical detection kit for detection and analysis |
| CN109100505A (en) * | 2018-08-22 | 2018-12-28 | 宁波奥丞生物科技有限公司 | A kind of immunofluorescent reagent box of quantitative detection blood vessel endothelium marker CD105 |
| CN111380724A (en) * | 2020-04-24 | 2020-07-07 | 万华普曼生物工程有限公司 | Body fluid sample collecting and inspecting device |
| CN111380724B (en) * | 2020-04-24 | 2023-08-25 | 万华普曼生物工程有限公司 | Body fluid sample sampling and detecting device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204758608U (en) | Detection apparatus for former content of half quantitative determination blood sample median calcitonin of colloidal gold method | |
| WO2018149131A1 (en) | Integrated device for faeces sampling and occult blood detection | |
| CN105699380A (en) | Analysis equipment and method for simultaneously measuring CRP (C-Reactive Protein) and blood routine | |
| US20140134051A1 (en) | Automated platelet function analyzer and its analytical methods | |
| CN205656141U (en) | But conventional analytical equipment of simultaneous measurement CRP and blood | |
| CN204666640U (en) | A kind of C reactive protein colloidal gold method half-quantitative detection device | |
| CN104949942A (en) | POCT (point-of-care testing) special protein analysis system | |
| CN108918866A (en) | A kind of marker of inflammation POCT combined detection kit suit | |
| CN217305198U (en) | Two joint inspection reagent card | |
| CN206725591U (en) | A kind of sampling device for immune quantitative analyzer | |
| CN104977407A (en) | Colloidal gold immunochromatography test paper strip for detecting tetracycline drugs, and preparation method thereof | |
| CN102043043A (en) | Multi-project biochemical test analysis integrated kit and method thereof | |
| CN102967701B (en) | Urine analysis system and analysis method thereof | |
| EP3221444A1 (en) | Lateral flow assay ratio test | |
| TWM502845U (en) | Reagent cartridge slot structure | |
| CN102182116B (en) | Preparation and application method of filter paper collecting biological sample | |
| CN204556647U (en) | A kind of fast joint quantitatively detects the chromatograph test strip of IGF-1 and IGFBP-3 and applies its pick-up unit | |
| CN103389374A (en) | Colloid gold kit for detecting mycoplasma pneumoniae by micro whole-blood loading method | |
| CN203798733U (en) | POCT (Point of Care Testing) specific protein analysis system | |
| CN204964523U (en) | Blood routine inspection POCT unites test paper | |
| CN100397080C (en) | Sanitary product possessing immune chromatography detection indication function | |
| CN210376396U (en) | C-reactive protein detection kit | |
| CN203396776U (en) | HIT (Heparin-Induced Thrombocytopenia) antibody detection immunofluorescence layer chromatography test strip | |
| EP2689248A1 (en) | Method for performing a rapid test | |
| CN205581125U (en) | Urine analyzer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151111 |